Hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) are a significant cause of morbidity and ...
Introduction Patients with chronic bronchitis suffer high morbidity and rapid functional decline; thus, novel treatments are ...
A 62-year-old man with a history of systemic Amyloid light-chain (AL) amyloidosis in prior haematological remission presented ...
Background Previous studies have shown that the incidence of idiopathic pulmonary fibrosis (IPF) is rising in the UK and USA. Death registrations and primary care data were used to determine the ...
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
Introduction Lung-function outcomes among preterm-born children referred for pulmonology care are highly heterogeneous, and early determinants remain incompletely defined. We aimed to identify ...
3 Department of Pathology, Faculty of Medicine, University of Valencia, Valencia, Spain Correspondence to: Dr E J Morcillo Department of Pharmacology, Faculty of Medicine, Av. Blasco Ibanez 15, ...
S Baudouin, S Blumenthal, B Cooper, C Davidson, A Davison, M Elliot, W Kinnear (Chairman), R Paton, E Sawicka, L Turner (Secretary) Non-invasive ventilation (NIV) refers to the provision of ...
Rationale Advanced fibrosing interstitial lung disease (ILD) is often progressive and associated with a high burden of symptoms and poor prognosis. Little is known about the symptom prevalence and ...
Division of Respiratory Medicine, City Hospital, Nottingham NG5 1PB, UK Correspondence to: Ms S Cooper, Division of Respiratory Medicine, Clinical Sciences Building, City Hospital, Nottingham NG5 1PB, ...
3 Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK 4 Department of Clinical Biochemistry, Hammersmith Hospital, Imperial College Healthcare NHS Trust, ...
Dr J B Soriano, Department of Worldwide Epidemiology, GlaxoWellcome R&D, Greenford, Middlesex UB6 0HE, UK email: jbs42397{at}glaxowellcome.co.uk BACKGROUND Recent trends in physician diagnosed chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results